Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-016905
Filing Date
2019-11-12
Accepted
2019-11-12 16:21:13
Documents
58
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 644585
2 ex3-1.htm EX-3.1 112606
3 ex10-1.htm EX-10.1 10766
4 ex10-2.htm EX-10.2 10890
5 ex10-3.htm EX-10.3 11723
6 ex10-3_001.jpg GRAPHIC 16683
7 ex10-4.htm EX-10.4 16430
8 ex31-1.htm EX-31.1 21140
9 ex31-2.htm EX-31.2 21152
10 ex32.htm EX-32 14220
11 form10-q_001.jpg GRAPHIC 67557
  Complete submission text file 0001493152-19-016905.txt   2883047

Data Files

Seq Description Document Type Size
12 XBRL INSTANCE FILE abeo-20190930.xml EX-101.INS 411886
13 XBRL SCHEMA FILE abeo-20190930.xsd EX-101.SCH 26866
14 XBRL CALCULATION FILE abeo-20190930_cal.xml EX-101.CAL 48208
15 XBRL DEFINITION FILE abeo-20190930_def.xml EX-101.DEF 89147
16 XBRL LABEL FILE abeo-20190930_lab.xml EX-101.LAB 203384
17 XBRL PRESENTATION FILE abeo-20190930_pre.xml EX-101.PRE 159748
Mailing Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019
Business Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15771 | Film No.: 191209769
SIC: 2834 Pharmaceutical Preparations